COVID-19 and Vaccine-Related Mental Health Issues in Children and Young Adults
- There is ongoing scientific debate about the increase in heart problems such as myocarditis and pericarditis in children and young adults.
- The first clear signals in the biomedical literature that the risk of heart inflammation was greater for boys and young men from the jab (Pfizer: 5.31 and Moderna...
- The risk of myocarditis in this large cohort study was highest in young males after the second SARS-CoV-2 vaccine dose, and this risk should be balanced against the...
There is ongoing scientific debate about the increase in heart problems such as myocarditis and pericarditis in children and young adults. is this caused by the COVID-19 virus, the COVID-19 vaccines, or a combination of both?
The first clear signals in the biomedical literature that the risk of heart inflammation was greater for boys and young men from the jab (Pfizer: 5.31 and Moderna 13.83 per 100,000) than from the virus (1.37 per 100,000) date back too April 2022 (Ref.1, see our article here).
The risk of myocarditis in this large cohort study was highest in young males after the second SARS-CoV-2 vaccine dose, and this risk should be balanced against the benefits of protecting against severe COVID-19 disease.
However, at the end of 2025 (online in November), an article appeared in The Lancet Child & Adolescent Health (2) suggesting the opposite: the risk of heart inflammation is higher after infection (2.24 per 100,000) than after vaccination (0.85 per 100,000). This finding was widely reported in the news and on social media in November.
How is that possible?
Illuminating is the letter of concern from researcher Dr. Clare Craig to The Lancet Child & adolescent Health (January 2026) regarding this article (link and also ref. 3).
Her main criticism of the Lancet Child & Adolescent Health study:
- The study analyzes infection and vaccination as separate events that do not influence each other. It does not take into account the effect of vaccination on subsequent infection. And that happens often: because vaccination does not prevent infection.
- Overestimation of infection risks: The study estimates 2.24 cases of myocarditis/pericarditis per 100,000 children up to 6 months after infection, but this is much higher than the 0.5 per 100,000 in an earlier study of unvaccinated individuals after Covid-19.
- Opaque corrections: Raw incidence after vaccination is 13.9 per 100,000 per year
“`html
Sam Altman is an American entrepreneur and investor best known as the CEO of OpenAI, the company behind ChatGPT and other artificial intelligence technologies.His leadership has been pivotal in the rapid advancement and deployment of AI, though his position and OpenAI’s governance structure have faced recent scrutiny and temporary disruption.
Sam Altman: Background and Career
Table of Contents
Sam Altman is an American entrepreneur and investor who currently serves as the CEO of OpenAI. He co-founded Loopt, a location-based social networking mobile app, in 2005, and served as its CEO until its acquisition in 2012. He then became a partner at Y Combinator,a startup accelerator,in 2014 and served as its president from 2019 to 2023.
Altman’s early career focused on mobile technology and seed-stage investing. He has invested in numerous successful companies,including Airbnb,Stripe,and Reddit. His transition to OpenAI marked a notable shift towards focusing on artificial intelligence research and development.
Example: Altman’s involvement with Airbnb began with a $20,000 investment in 2009, demonstrating his early ability to identify promising startups. TechCrunch reported on this early investment in 2015.
OpenAI and ChatGPT
OpenAI is an artificial intelligence research and deployment company whose mission is to ensure that artificial general intelligence (AGI) benefits all of humanity. Sam Altman became CEO of OpenAI in December 2019. Under his leadership, OpenAI released ChatGPT in November 2022, a large language model chatbot that quickly gained widespread attention for its ability to generate human-quality text.
ChatGPT’s release spurred significant public discussion about the potential and risks of AI. OpenAI has continued to develop and refine its models,including GPT-4,and has partnered with Microsoft to integrate its technology into various products.
Example: ChatGPT reached 100 million users in January 2023, becoming the fastest-growing consumer submission in history. Reuters reported this milestone on January 31, 2023.
November 2023 Board Dispute and Reinstatement
In November 2023, Sam Altman was abruptly removed as CEO of OpenAI by the company’s board of directors. The board cited a lack of candor in his communications as the reason for his removal. This decision triggered a significant crisis within OpenAI, with widespread concern from investors and employees.
Following intense negotiations, and pressure from Microsoft, who had invested billions in OpenAI, Altman was reinstated as CEO on November 22, 2023. A new board of directors was also appointed, including Bret Taylor, Larry Summers, and Adam D’angelo (who was the only holdover from the previous board). The circumstances surrounding Altman’s initial removal and reinstatement remain somewhat opaque, but the event highlighted tensions regarding the control and direction of OpenAI.
example: Microsoft CEO Satya Nadella announced Microsoft’s commitment to OpenAI following Altman’s initial removal, stating that Microsoft remained “confident in our partnership with openai.” Microsoft Blog published Nadella’s statement on November 20, 2023.
Several entities are closely related to Sam Altman and his work at OpenAI. These include:
- OpenAI: The artificial intelligence research and deployment company. openai.com
- Microsoft: A major investor in OpenAI and partner in developing and deploying AI technologies. microsoft.com
- Y Combinator: The startup accelerator where Altman previously served as president. ycombinator.com
- Bret taylor: Chairman of OpenAI’s board